Higher SCN7A expression regardless of mRNA or protein expression was related to a better outcome in HCC patients, and even the DNA mutation and DNA methylation level of SCN7A could distinguish the different outcomes in HCC. This evidence concerns the gene SCN7A and hepatocellular carcinoma.